Press "Enter" to skip to content

Real Time Voice Analyzer: The Future of COVID Screening

Revolutionizing the screening process for respiratory viruses, the Real Time Voice Analyzer (RTVA) is now the most advanced non-invasive COVID screening tool available. Utilizing voice biomarkers and powered by innovative AI algorithms, the RTVA offers fast, accurate, and easy screening for COVID-19, its latest variants, and even strains of influenza and the common cold.

The Science Behind the Innovation

Developed under the expertise of Dr. Rita Singh, an internationally renowned voice analysis researcher, the RTVA’s cutting-edge technology identifies airborne respiratory viruses just from the sound of your voice, much like a doctor uses a stethoscope to detect vital organ irregularities. The AI algorithms are so precise they offer results with a 99% negative predictive rate, providing assurance that a negative result almost certainly means you’re free from COVID.

Additionally, the RTVA has the capability to work across diverse languages and dialects, primarily utilizing vowel sounds to ensure consistent and accurate results for users worldwide. This level of inclusivity is a game-changer in the realm of medical diagnostics.

User-Centric Features

  • Simple and Non-Invasive: Say goodbye to uncomfortable nasal swabs. RTVA offers health monitoring without physical contact.
  • Fast and Reliable Results: Screening results are available within 5-10 minutes.
  • Convenience: The app can be accessed anywhere, anytime, aligning with the needs of modern users.
  • Privacy First: User health data is secure and 100% HIPAA Compliant.
  • Environmental Impact: A zero-waste solution, RTVA needs only your voice, meaning no plastics, swabs, or excessive packaging.

In Case of Positive Screening

Should users receive a positive screening, it’s an indication that the AI has detected an airborne respiratory virus. Following such results, the user should consider undergoing further tests such as a COVID Rapid test or PCR Test. The RTVA acts as an early warning system but is not a definitive diagnostic tool, so medical consultation is advisable.

A Credible Innovation

Behind this incredible technology is Dr. Rita Singh, with over 25 years of experience in voice analysis research. Affiliated with Carnegie Mellon University, Dr. Singh’s innovations have been recognized and validated by institutions like Yale University School of Medicine, M.I.T, and medical clinics globally.

Melinda Silva, MD, and a member of RTVA’s Medical Advisory Board, lauds the technology, stating, “The Real Time Voice Analyzer is an incredibly useful early warning tool.” She emphasizes its role in enabling individuals to manage their respiratory health proactively.

The Mobile Health App and Its Future

Real Time Voice Analyzer App Overview

As showcased in the above video, the RTVA, in collaboration with Hematico, is poised to redefine COVID screening. Available for a no-charge trial, it’s an environmentally friendly, non-invasive tool that holds the future of respiratory health monitoring.

For more information, visit

About Real Time Network

Established in 1998, Real Time Network has been at the forefront of healthcare solutions, providing effective, affordable, and accessible products and services. Co-founders Ron Snodgrass and Tim Flatt’s combined expertise has shaped Real Time into a trusted name in the industry.